Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Liu, Dai-Hong  [Clear All Filters]
2024
Ma C, Chen P, Du J, Wang L, Lu N, Sun J, Qilong X, Wang Y, Dou L, Liu D-H. Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation. J Immunother Cancer. 2024;12(1).
Shan R-Q, Huang S, Gu Z-Y, Wang N, Liu D-H, Dou L-P. [Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Gene Mutation]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024;32(2):327-334.
2023
An Z-Y, Wu Y-J, Hou Y, Mei H, Nong W-X, Li W-Q, Zhou H, Feng R, Shen J-P, Peng J, et al. A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study. Sci Bull (Beijing). 2023.
2022
Xu L-P, Lu D-P, Wu D-P, Jiang E-L, Liu D-H, Huang H, Sun Z-M, Li N-N, Liu Q-F, Zhang X, et al. Hematopoietic stem cell transplantation activity in China 2020-2021 during the SARS-CoV-2 pandemic: a report from the Chinese Blood and Marrow Transplantation Registry Group. Transplant Cell Ther. 2022.
Luan S-H, Ma Y-Q, Yang J-J, Wang H, Liu D-H, Dou L-P. [The Prognostic Value of FOSB Gene in Acute Myeloid Leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022;30(4):1063-1070.
2019
Chen Y, Fu W-J, Xu L-P, Ren H-Y, Lai Y-R, Liu D-H, Liu L, Sun Z-M, Bin Wu Y-, Wang X, et al. Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myeloma. Chin Med J (Engl). 2019.
2013
Han T-T, Xu L-P, Liu D-H, Liu K-Y, Fu H-X, Zhao X-Y, Zhao X-S, Huang X-J. Cytomegalovirus is a potential risk factor for late-onset hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2013.